A01K 2267/00
Animals characterised by purpose
A01K2267/00 (Animals characterised by purpose) appears on 4,402 US grants and 8,167 published applications in this corpus.
Search patents in A01K- Granted patents
- 4,402
- Published applications
- 8,167
- Assignees
- 2,642
- Inventors
- 14,168
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 6 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 12 | 0 |
| 1996 | 56 | 0 |
| 1997 | 75 | 0 |
| 1998 | 121 | 0 |
| 1999 | 122 | 0 |
| 2000 | 119 | 0 |
| 2001 | 123 | 27 |
| 2002 | 91 | 258 |
| 2003 | 118 | 355 |
| 2004 | 98 | 312 |
| 2005 | 80 | 359 |
| 2006 | 132 | 382 |
| 2007 | 130 | 332 |
| 2008 | 116 | 320 |
| 2009 | 138 | 339 |
| 2010 | 162 | 347 |
| 2011 | 148 | 315 |
| 2012 | 143 | 253 |
| 2013 | 156 | 242 |
| 2014 | 134 | 253 |
| 2015 | 164 | 288 |
| 2016 | 156 | 282 |
| 2017 | 165 | 280 |
| 2018 | 164 | 297 |
| 2019 | 159 | 365 |
| 2020 | 185 | 432 |
| 2021 | 193 | 418 |
| 2022 | 175 | 438 |
| 2023 | 179 | 386 |
| 2024 | 194 | 371 |
| 2025 | 227 | 319 |
| 2026 | 144 | 197 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Method for producing genetically edited birds having resistance to avian influenza viruses22 Sep 2026US 12,742,180 B2Seoul National University R&Db Foundation
- Non-canonical SWI/SNF complex and uses thereof8 Sep 2026US 12,729,225 B2Dana-Farber Cancer Institute, Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996